House Patent Reform Bill: Battle Looms Over Reexam, Prior User Rights Provisions

The six-year battle over patent reform legislation is not yet over as the pharmaceutical and biotechnology industries and other leading stakeholders are unhappy with provisions in the House bill that differ from the recently passed Senate measure.